Mark Hoskins KC KC > Brick Court Chambers > London, England > Barrister Profile

Brick Court Chambers
7-8 ESSEX STREET
LONDON
WC2R 3LD
England
Mark Hoskins KC photo

Position

Mark Hoskins was called to the Bar of England and Wales in 1991 and was appointed QC in 2009. He was called to the Irish Bar in 2017 and is a member of the Law Library. He is widely regarded as one of the leading litigators in the fields of competition, EU/EEA, Administrative & Public and Sports law. He is renowned as a “highly skilled analytical advocate” and “very good at working within a team”.

Lawyer Rankings

London Bar > Competition

(Leading Silks)Ranked: Tier 1

Mark Hoskins KCBrick Court ChambersMark remains one of the very best, if not the best, in his field of expertise. He cuts through complexity and is concise and precise in has written and oral advocacy.’

Brick Court Chambers continues to handle the leading cases in the field of competition law, advising both claimants and defendants across the spectrum of competition areas, from state aid and cartels to abuse of dominant positions and contested mergers. Mark Hoskins KC leads, among others, Sarah Abram KC, who took silk in 2022, in acting for leading mobile operators, including O2 and Telefonica, in a damages claim brought by Phones4U for around £800m; the retailer collapsed into administration in 2014 alleging that the networks conspired to drive it out of business. Marie Demetriou KC continues to lead Victoria Wakefield KC among others in Merricks v Mastercard, the first collection action certified by the CAT, with more proceedings in 2023 following the success in the Court of Appeal in late 2022 – the case seeks damages for virtually every adult in the UK, who allegedly paid inflated prices owing to the payment network’s interchange fees. In Allergen & Ors v CMA, Robert O’Donoghue KC led Emma Mockford when acting Cinven – previous owner of a business now forming part of Advanz Pharmaceuticals – in its appeal against the regulator’s 2021 decision that drug companies overcharged the NHS for hydrocortisone tablets.